Back to mobile site
Get it on Google Play

Rhythm Pharmaceuticals schedules call on Prader-Willi syndrome trial data

June 12, 2026 4:01 PM EDT Send to a Friend
Rhythm Pharmaceuticals Inc. (NASDAQ: RYTM) announced it will host a conference call on June 13 at 9:00 a.m. ET to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login